Literature DB >> 19795477

Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.

Davide Manca, Giovanni Cossu, Daniela Murgia, Andrea Molari, Paola Ferrigno, Emanuele Marcia, Maurizio Melis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19795477     DOI： 10.1002/mds.22807

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  21 in total

1.  PINK1: pumps, paraesthesia, punding and psychosis.

Authors:  Dominic C Paviour; Marie-Helene Marion
Journal:  J Neurol       Date:  2011-11-30       Impact factor: 4.849

Review 2.  Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert.

Authors:  Diego Santos-García; Raúl de la Fuente-Fernández; Francesc Valldeoriola; Antonio Palasí; Fátima Carrillo; Mónica Grande; Pablo Mir; Oriol De Fabregues; Jordi Casanova
Journal:  J Neurol       Date:  2012-01-24       Impact factor: 4.849

3.  Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.

Authors:  Thomas Müller; Constanze Jugel; Reinhard Ehret; Georg Ebersbach; Gunar Bengel; Siegfried Muhlack; Fabian Klostermann
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

Review 4.  Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.

Authors:  Johan Virhammar; Dag Nyholm
Journal:  Ther Adv Neurol Disord       Date:  2016-12-01       Impact factor: 6.570

Review 5.  Novel Levodopa Formulations for Parkinson's Disease.

Authors:  Maria Eliza Freitas; Marta Ruiz-Lopez; Susan H Fox
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

6.  Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation.

Authors:  Sophie M Lehnerer; Urban M Fietzek; Michael Messner; Andres O Ceballos-Baumann
Journal:  J Neural Transm (Vienna)       Date:  2014-04-08       Impact factor: 3.575

7.  Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.

Authors:  Sabitha Joseph; Siv Vingill; Olaf Jahn; Robert Fledrich; Hauke B Werner; Istvan Katona; Wiebke Möbius; Mišo Mitkovski; Yuhao Huang; Joachim Weis; Michael W Sereda; Jörg B Schulz; Klaus-Armin Nave; Judith Stegmüller
Journal:  J Neurosci       Date:  2019-05-13       Impact factor: 6.167

Review 8.  Hyperkinetic Movement Disorder Emergencies.

Authors:  Giovanni Cossu; Carlo Colosimo
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

9.  Is there room for new non-dopaminergic treatments in Parkinson's disease?

Authors:  Manuela Pilleri; Konstantinos Koutsikos; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2012-12-11       Impact factor: 3.575

Review 10.  Laboratory assessments in the course of Parkinson's disease: a clinician's perspective.

Authors:  Thomas Müller; Horst Baas; Jan Kassubek; Peter Riederer; Peter Paul Urban; Christoph Schrader; Heinz Reichmann; Dirk Woitalla; Manfred Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2015-11-14       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.